Matthew Plunkett, Ph.D.
Senior Vice President & Chief Financial Officer, Nkarta Therapeutics
Matthew Plunkett, Ph.D. joined Nkarta in 2018 as Senior Vice President and Chief Financial Officer. Dr. Plunkett was most recently Chief Financial and Business Officer of Medeor Therapeutics, a development stage cell therapy company, where he led the completion of a $57 million Series B financing. Prior to Medeor, from September 2012 to August 2017 he held positions as Chief Business Officer and Executive Vice President, Corporate Development at CTI BioPharma, a commercial stage hematology-oncology biotech company. He was Chief Financial Officer of the California Institute for Regenerative Medicine from November 2011 to August 2012. Dr. Plunkett was the Vice President and Chief Financial Officer of iPierian, Inc. from July 2009 to April 2011. From December 2000 to July 2009, Dr. Plunkett held positions at Oppenheimer & Co. and its U.S. predecessor, CIBC World Markets Corp., including serving as Managing Director, Head of West Coast Biotechnology from December 2008 to July 2009, and Executive Director, Head of West Coast Biotechnology from January 2008 to December 2008. Dr. Plunkett received his BS in chemistry from Harvey Mudd College and a PhD in organic chemistry from the University of California, Berkeley.